A. Rietveld

发表

Renal replacement therapy in lupus nephritis.

J. Berden, A. Rietveld, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus

C. Saris, B. V. van Engelen, J. Gottenberg, 2018, Front. Immunol..

Inclusion body myositis in patients with spinocerebellar ataxia types 3 and 6

C. Saris, B. P. Van de Warrenburg, B. V. van Engelen, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Muscle fiber dysfunction contributes to weakness in inclusion body myositis

C. Saris, A. Heerschap, B. Engelen, 2017, Neuromuscular Disorders.

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

J. Lamb, C. Saris, B. V. van Engelen, 2017, Annals of the rheumatic diseases.

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

J. Lamb, M. Roberts, C. Saris, 2017, Annals of the rheumatic diseases.

Autoantibody testing in idiopathic inflammatory myopathies

C. Saris, B. V. van Engelen, O. Benveniste, 2019, Practical Neurology.

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis

G. Pruijn, C. Saris, B. V. van Engelen, 2021, Arthritis & rheumatology.

IMPLICATIONS OF ANTI-CN1A SEROTYPE IN INCLUSION BODY MYOSITIS

J. Lamb, B. V. van Engelen, S. Pye, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

J. Lamb, M. Verbeek, L. Pleštilová, 2015, Annals of the rheumatic diseases.

Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro

A. Pradier, Ning Li, C. Vonarburg, 2019, Frontiers in Immunology.

Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

C. M. Haring, J. Berden, Catharina M Haring, 2012, Journal of the American Society of Nephrology : JASN.

Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy

C. Saris, J. D. De Bleecker, A. J. van der Kooi, 2018, Neurology: Neuroimmunology & Neuroinflammation.

Diagnostic struggles in congenital myasthenic syndromes in children

N. Alfen, E. Kamsteeg, C. Erasmus, 2014, Journal of Pediatric Neurology.

Renal replacement therapy in lupus nephritis.

J. Berden, A. Rietveld, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

C. M. Haring, J. Berden, A. Rietveld, 2012, Journal of the American Society of Nephrology : JASN.